Literature DB >> 11450793

Proximal compared with distal gastric cancer: multivariate analysis of prognostic factors.

F Pacelli1, V Papa, P Caprino, A Sgadari, M Bossola, G B Doglietto.   

Abstract

The major determinants of the poor prognosis of the patients with proximal-third gastric cancer (proximal gastric cancer or PGC) when compared with that of patients with more distally located gastric tumors (distal gastric cancer or DGC) rely both on the more advanced age and tumor stage at the moment of clinical presentation and on the higher postoperative mortality for PGC patients. We reviewed hospital records of 707 patients with gastric cancer (187 with PGC and 520 with DGC) observed during the period 1981 through 1996 at the same surgical unit. Demographic and pathological data, type of treatment, and hospital morbidity and mortality rates were recorded. Univariate and multivariate survival analysis was used to calculate the 5-year survival probabilities with respect to the following clinical and pathological variables: age, sex, gross appearance according to Borrmann classification, histological type according to Lauren, stage of the disease, tumor location, and type of treatment. PGC was associated with more advanced tumor stage (P < 0.0001), older age (P = 0.039), and higher necessity of extended surgery (P < 0.0001) when compared with DGC. Hospital mortality was 9.6 and 5 per cent in PGC and DGC patients respectively (P = 0.033). Overall 5-year survival was 17.7 and 36.4 per cent in PGC and DGC patients (P < 0.0001): 35.9 versus 57.6% (P = 0.0001) and 3.7 versus 7.6 per cent (P = 0.03) after radical and palliative surgery respectively. At multivariate survival analysis proximal location was found to be independently associated (P = 0.0007) with poor survival. The multivariate model shows the proximal location as an independent predictor of lesser favorable outcome in gastric cancer. The major determinants of the poor prognosis of PGC with respect to DGC rely both on the more advanced age and tumor stage at the moment of clinical presentation and on the higher postoperative morbidity for PGC patients.

Entities:  

Mesh:

Year:  2001        PMID: 11450793

Source DB:  PubMed          Journal:  Am Surg        ISSN: 0003-1348            Impact factor:   0.688


  20 in total

1.  Prognostic factors for patients after curative resection for proximal gastric cancer.

Authors:  Donghui Zhao; Huimian Xu; Kai Li; Zhe Sun
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2010-08-17

2.  SOD2 rs4880 CT/CC genotype predicts poor survival for Chinese gastric cancer patients received platinum and fluorouracil based adjuvant chemotherapy.

Authors:  Zhi Xu; Yi Chen; Dongying Gu; Nikki P Lee; Stella Sun; Weida Gong; Yongfei Tan; John M Luk; Jinfei Chen
Journal:  Am J Transl Res       Date:  2015-02-15       Impact factor: 4.060

3.  Comparison of Outcomes for Elderly Gastric Cancer Patients at Least 80 Years of Age Following Gastrectomy in the United States and China.

Authors:  Jian-Xian Lin; Brendan C Yi; Changhwan Yoon; Ping Li; Chao-Hui Zheng; Chang-Ming Huang; Sam S Yoon
Journal:  Ann Surg Oncol       Date:  2018-09-14       Impact factor: 5.344

4.  Prediction of recurrence after radical surgery for gastric cancer: a scoring system obtained from a prospective multicenter study.

Authors:  Daniele Marrelli; Alfonso De Stefano; Giovanni de Manzoni; Paolo Morgagni; Alberto Di Leo; Franco Roviello
Journal:  Ann Surg       Date:  2005-02       Impact factor: 12.969

5.  Correlation between the current TNM staging and long-term survival after curative D1 lymphadenectomy for stomach cancer.

Authors:  Saleh M Abbas; M W Booth
Journal:  Langenbecks Arch Surg       Date:  2005-01-15       Impact factor: 3.445

6.  Significant Racial Disparities Exist in Noncardia Gastric Cancer Outcomes Among Kaiser Permanente's Patient Population.

Authors:  Marita C Bautista; Sheng-Fang Jiang; Mary Anne Armstrong; Sanjay Kakar; Debbie Postlethwaite; Dan Li
Journal:  Dig Dis Sci       Date:  2014-10-30       Impact factor: 3.199

7.  Ethnic disparities in gastric cancer incidence and survival in the USA: an updated analysis of 1992-2009 SEER data.

Authors:  Felix H Lui; Bertrand Tuan; Sara L Swenson; Robert J Wong
Journal:  Dig Dis Sci       Date:  2014-07-17       Impact factor: 3.199

8.  The prognostic effect of ethnicity for gastric and esophageal cancer: the population-based experience in British Columbia, Canada.

Authors:  Morteza Bashash; T Greg Hislop; Amil M Shah; Nhu Le; Angela Brooks-Wilson; Chris D Bajdik
Journal:  BMC Cancer       Date:  2011-05-09       Impact factor: 4.430

9.  MED30 Regulates the Proliferation and Motility of Gastric Cancer Cells.

Authors:  Yong Joo Lee; Myoung-Eun Han; Su-Jin Baek; Seon-Young Kim; Sae-Ock Oh
Journal:  PLoS One       Date:  2015-06-25       Impact factor: 3.240

10.  Changes in treatment outcomes of gastric cancer surgery over 45 years at a single institution.

Authors:  Woo Jin Hyung; Sung Soo Kim; Won Hyuk Choi; Jae Ho Cheong; Seung Ho Choi; Choong Bai Kim; Sung Hoon Noh
Journal:  Yonsei Med J       Date:  2008-06-30       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.